13. Mohd R, Husain A, Mishra, et al. Syntehsis and anti anxiety activity of some
7-chloro-5-phenyl-1,3-dihydro-1H,3H-1,4-benzodiazepine-2-one derivatives
in mice. Der Pharmacia Lettre 2010; 2(1) 253-260.
14. Katzung, B. G., 2004. Basic & clinical pharmacology 12 th edition. McGrawHill Companies. 2007.
15. Ali R, Moghaddam S, Pashazadeh, et al. Study of sedation, Pre-anesthetic and
anti-anxiety effects of Salix Aegyptiaca herbal extract in comparison with
diazepam in rats. IOSR-JPBS 2013; 6(2): 17-20.
16. Farabelli C, Ricca V, and Truglia E. Panic Disorder: Pathogenesis and
treatment. In: Anxiety disorders an introduction to clinical management and
research: UK: Jhon Wiley & Sons Ltd, 2001.
17. Saddock BJ & Saddock VA. Panic disorder and agoraphobia. In: Kaplan &
Sadock's Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry,
10th Ed. USA: Lippincott Williams & Wilkins; 2007.
18. Mohammed AM. Panic disorder. [online] Medscape 2011 [cited 2013 May
28]; Available from: URL: http://emedicine.medscape.com/article/287913overview
19. Choy Y. Managing side effects of anxiolytics. Primary Psychiatry 2001; 14
(7): 68-72.
20. Anonymous. Antianxiety drugs the facts about effects. Los Angeles: CCHR
International. 2006
21. Western Australian Psychotropic Drugs Committee. Anxiety disorders drug
treatment guidlines. Departement of Health: Australia. 2008.